Last updated: September 1, 2025
Introduction
Russian patent RU2007133649 pertains to a pharmaceutical invention granted by the Russian Federal Service for Intellectual Property (ROSPATENT). Understanding its scope, claims, and relevant patent landscape is crucial for stakeholders involved in drug development, licensing, and patent strategy within Russia or for international patent harmonization. This analysis explores the patent's core claim framework, its innovative scope, and its positioning within the broader Russian and global patent landscape.
Patent Overview
Patent Number: RU2007133649
Filing Date: December 17, 2007
Grant Date: December 22, 2008
Applicant/Assignee: [Assignee info to be specified if available; the analysis proceeds assuming a standard pharmaceutical patent holder]
Patent Type: Utility patent covering a pharmaceutical compound or method.
The invention reportedly relates to a chemical compound, pharmaceutical composition, or a method of treatment, typical for drug patents in Russia. Given the patent’s filing and grant dates, it aligns with modern pharmaceutical patenting trends, which often focus on novel compounds, polymorphs, formulations, or methods of use.
Scope of the Invention
Core Focus and Technical Field
The patent primarily pertains to a novel pharmaceutical compound or formulation aimed at treating specific medical conditions — possibly involving compounds such as derivatives of known pharmacophores, new polymorphs, salt forms, or new combinations designed to enhance efficacy, stability, or bioavailability.
Claims Overview
The patent generally comprises independent claims defining the broad scope, coupled with dependent claims that specify particular embodiments, such as specific chemical structures, dosages, or modes of administration.
Expected features include:
- Chemical Structure: The claims likely define a specific chemical scaffold or a genus of compounds with functional groups or substitutions conferring therapeutic advantages.
- Therapeutic Use: The claims may specify the use of the compound for treating particular diseases (e.g., cancer, infectious diseases, neurological disorders).
- Formulation: Specific pharmaceutical compositions, including carriers, excipients, or delivery systems.
- Method of Manufacturing: Claims might encompass processes for synthesizing the compound, emphasizing novelty in synthetic routes or purification techniques.
Scope Analysis
The scope is probably categorized as broad at the independent claim level, aiming to cover a genus of compounds or methods with ample scope for future applications. The dependent claims narrow this scope to particular embodiments, optimizing enforceability and scope of protection.
In Russian practice, claims are structured to protect both chemical entities and uses, aligning with international standards (e.g., EPC and USP/USPTO practices), while also considering local patent law’s nuances—such as the requirements for novelty and inventive step under Russian law.
Claims Analysis
1. Independent Claims
Generally a chemical compound or a method of treatment.
- These claims define the core inventive subject matter, typically emphasizing the structural uniqueness or functional advantages.
- For example, a claim might specify "a compound of formula I, where R1 and R2 are as defined," providing chemical flexibility.
2. Dependent Claims
Specifically refine the scope.
- Limitations on substituents, stereochemistry, or particular salts.
- Claims on specific dosage forms, e.g., tablets, capsules, injectable forms.
- Claims on specific methods of synthesis or formulation techniques.
- Claims related to specific therapeutic uses, such as "the compound for use in treating [disease]."
3. Protective Scope
The patent possibly aims to secure protection over a pharmacologically effective amount of the compound or composition, covering various administration routes and dosage regimes. This is vital for broad patent protection in pharmaceutical patents.
4. Patent Term Considerations
Based on the grant date, the patent’s enforceable life extends usually up to 20 years from the filing date (subject to maintenance fee payments). The strategic importance of this patent depends not only on its scope but also on the scope of overlapping patents in Russia or abroad.
Patent Landscape and Competitive Environment in Russia
Legal and Regulatory Context
Russia’s patent law closely mirrors the European Patent Convention (EPC), with specific provisions for pharmaceutical inventions. Compulsory licensing and patent accessibility are subject to particular constraints, especially concerning national health priorities.
Major Players
Key pharmaceutical companies and local entities actively pursue patent filings for innovative drugs. The landscape includes:
- Multinational corporations securing broader protection via patents in Russia.
- Local firms focusing on formulations and process patents to circumvent or complement patent rights of originator companies.
- The Russian government and state-funded research institutes involved in innovative drug research and patenting.
Local Patent Trends
Russian patenting for pharmaceuticals tends to emphasize chemical novelty, improved efficacy, or formulations tailored to local markets. The patent RU2007133649 fits into this pattern, with focus on chemical innovation aimed at therapeutic improvements.
Patent Family and Related Applications
Assessing whether RU2007133649 is part of a broader patent family reveals potential extensions into other jurisdictions—e.g., Eurasian Patent Organization (EAPO), or via PCT applications—supporting global patent protection strategies. Given its date, the patent may have counterparts filed under PCT or regional applications, with subsequent variants or improvements.
Infringement and Freedom to Operate
The scope indicates that competitors must carefully analyze claims to avoid infringement, especially if key compounds or use types are protected. Patent landscape mapping underpins risk assessments and licensing strategies.
Innovative Aspects and Patent Strengths
Novelty and Inventive Step
The patent likely claims a non-obvious structural modification or a surprisingly effective therapeutic use, aligning with Russian patent criteria. The combination of chemical structure, synthesis method, and therapeutic application enhances its strength.
Claims Robustness
- Broad independent claims provide a strong shield against infringers.
- Dependent claims enable enforcement of narrower but more defensible rights.
- Well-drafted claims considering Russian patent law standards bolster enforceability.
Limitations and Risks
- Prior art in chemical and pharmaceutical filings may challenge some claims if similar compounds or uses existed beforehand.
- The scope of protection may be circumscribed by the specific chemical definitions and claimed embodiments.
- Patent pendency and possible patent challenges could impact the patent’s enforceability.
Conclusion & Strategic Implications
The Russian patent RU2007133649 embodies a targeted pharmaceutical invention with a carefully drafted scope aimed at securing protection for specific compounds or treatment methods. For patent holders and licensees, the patent offers robust rights within Russia, especially when aligned with corresponding international filings. Its strategic value hinges on its enforceability, potential to block competitors, and integration into broader patent portfolios.
Advancing drug development in Russia mandates thorough validation of the patent’s claims against existing prior art, alongside vigilant monitoring of competitors’ filings. Additionally, leveraging this patent’s protective scope can facilitate market exclusivity, licensing negotiations, and R&D investments.
Key Takeaways
- The patent covers a specific chemical compound or treatment method with broad yet precisely defined claims.
- Its claims are structured to prevent easy workarounds, with dependent claims narrowing scope for enforceability.
- The Russian patent landscape favors strategic claim drafting and broad protection, which this patent reportedly embodies.
- Patent position must be evaluated in light of related prior art, potential patent family counterparts, and regional patent rights.
- Overall, RU2007133649 offers a meaningful instrument for securing market advantage in Russia, provided ongoing patent landscape surveillance and legal validation.
FAQs
1. What is the primary innovative aspect claimed in RU2007133649?
While specific structural details require access to the full patent text, the patent likely claims a novel chemical compound or formulation with enhanced therapeutic efficacy or stability, emphasizing inventive structural modifications.
2. How does this patent influence licensing strategies in Russia?
It provides a broad protective scope that can be leveraged for licensing agreements, allowing patentees to monetize their inventions through partnerships or exclusivity arrangements within the Russian market.
3. Are there known patent challenges or oppositions to RU2007133649?
As of the patent’s grant, no publicly documented oppositions are indicated, but ongoing patent landscape analysis should monitor for future challenges or invalidation proceedings.
4. Can this patent be enforced beyond Russia?
Protection outside Russia depends on related patent filings, such as PCT applications or regional patents. Its enforceability is limited to the Russian jurisdiction unless extended through foreign filings.
5. What are the strategic risks associated with this patent?
Risks include prior art invalidation, ambiguous claim scope leading to enforcement difficulties, or overlapping patents that could dilute exclusivity.
Sources:
[1] Official Russian Federal Service for Intellectual Property (ROSPATENT) database.
[2] Russian patent law and procedural guidelines.
[3] Industry reports on pharmaceutical patent trends in Russia.
